Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDINAL: Adalat XL vs Tiazac XC in Diabetic Nephropathy
NCT00713011Phase 3Withdrawn
- Sponsor
- Bayer
- Start
- Nov 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of nifedipine in diabetic nephropathy (DN), hypertension (HTN), sponsored by Bayer. Planned start Nov 2008; status: withdrawn.
02
Drugs
nifedipine
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00713011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713011.